Skip to main content
. 2015 Jul 21;10(7):e0133854. doi: 10.1371/journal.pone.0133854

Fig 5. GPR18 is dispensable for resistance to C. rodentium infections and graft versus host disease.

Fig 5

(A) 5 x 106 bone marrow cells from Gpr18 -/- or Gpr18 +/+ mice were transplanted into sublethally irradiated wild type CD45.1 recipients. Intestinal IEL chimerism was measured 8 weeks post-transplantation. Mean values ± SEM are shown. *p<0.05 using student's 2-tailed unpaired t-test. (B) Gpr18 -/- or Gpr18 +/+ bone marrow chimeras were orally gavaged with C. rodentium. Weight after infection was quantified for 37 days. Mean values ± SEM are shown, n = 10 for each group. No statistically significant differences were observed at any timepoint by students' 2-tailed t test. (C) Lethally-irradiated (900 cGy) Balb/c mice were transplanted with 5 x 106 T cell-depleted bone marrow cells from a CD45.1+ C57Bl/6 mice with or without 5 x 105 splenic pan T cells from CD45.2+ Gpr18 +/+ or Gpr18 -/- littermates. Survival was measured over the course of 50 days. Two recipients of T cell-depleted bone marrow only, 10 recipients of Gpr18 -/- splenic pan T cells, and 5 recipients of Gpr18 +/+ splenic pan T cells were assessed. No significant differences (p = 0.49) in survival were observed using log-rank Mantel-Cox test.